Evidence map›Paper›PMID 30730998›Full record

ArticlePloS one2019

Time and age trends in smoking cessation in Europe.

Giancarlo Pesce, Alessandro Marcon, Lucia Calciano, Jennifer L Perret, Michael J Abramson, Roberto Bono, Jean Bousquet, Alessandro G Fois, Christer Janson, Deborah Jarvis and 11 more

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Outpatients' cardiac rehabilitation: the long-term experience of the Niguarda Hospital.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Giancarlo PesceUnit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.ORCID 0000-0003-4925-6325
Alessandro MarconUnit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.ORCID 0000-0002-2778-658X
Lucia CalcianoUnit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Jennifer L PerretAllergy and Lung Health Unit, School of Population and Global Health, University of Melbourne, Melbourne, Australia.
Michael J AbramsonDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
Roberto BonoDepartment of Public Health and Pediatrics, University of Turin, Turin, Italy.
Jean BousquetUniversity Hospital and INSERM, Hôpital Arnaud de Villeneuve, Montpellier, France.
Alessandro G FoisClinical and Interventional Pulmonology, Department of Clinical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Christer JansonDepartment of Medical Sciences: Respiratory, Allergy and Sleep research, Uppsala University, Uppsala, Sweden.
Deborah JarvisNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Rain JõgiDepartment of Pneumology, University of Tartu, Tartu, Estonia.
Bénédicte LeynaertUMR1152, Department of Pathophysiology and Epidemiology of Respiratory Diseases, INSERM, Paris, France.
Dennis NowakInstitute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich (LMU), Munich, Germany.
Vivi SchlünssenDepartment of Public Health, Environment, Occupation and Health, Aarhus University, Aarhus, Denmark.
Isabel Urrutia-LandaRespiratory Department, Galdakao Hospital, OSI Barrualde-Galdakao, Biscay, Spain.
Giuseppe VerlatoUnit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Simona VillaniUnit of Biostatistics and Clinical Epidemiology, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
Torsten ZuberbierAllergy Centre Charité, Department of Dermatology & Allergy, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Cosetta MinelliNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Simone AccordiniUnit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Ageing Lungs in European Cohorts (ALEC) study

Funding

Medical Research Council G0901214Medical Research Council MR/L01341X/1
6 · The paper itself

Abstract

backgroundSmoking is the main risk factor for most of the leading causes of death. Cessation is the single most important step that smokers can take to improve their health. With the aim of informing policy makers about decisions on future tobacco control strategies, we estimated time and age trends in smoking cessation in Europe between 1980 and 2010.

methodsData on the smoking history of 50,228 lifetime smokers from 17 European countries were obtained from six large population-based studies included in the Ageing Lungs in European Cohorts (ALEC) consortium. Smoking cessation rates were assessed retrospectively, and age trends were estimated for three decades (1980-1989, 1990-1999, 2000-2010). The analyses were stratified by sex and region (North, East, South, West Europe).

resultsOverall, 21,735 subjects (43.3%) quit smoking over a total time-at-risk of 803,031 years. Cessation rates increased between 1980 and 2010 in young adults (16-40 years), especially females, from all the regions, and in older adults (41-60 years) from North Europe, while they were stable in older adults from East, South and West Europe. In the 2000s, the cessation rates for men and women combined were highest in North Europe (49.9 per 1,000/year) compared to the other regions (range: 26.5-32.7 per 1,000/year). A sharp peak in rates was observed for women around the age of 30, possibly as a consequence of pregnancy-related smoking cessation. In most regions, subjects who started smoking before the age of 16 were less likely to quit than those who started later.

conclusionsOur findings suggest an increasing awareness on the detrimental effects of smoking across Europe. However, East, South and West European countries are lagging behind North Europe, suggesting the need to intensify tobacco control strategies in these regions. Additional efforts should be made to keep young adolescents away from taking up smoking, as early initiation could make quitting more challenging during later life.

Indexed as

AdolescentAdultAge DistributionEuropeFemaleHealth PromotionHumansMaleMiddle AgedRetrospective StudiesSex FactorsSmoking CessationTobacco SmokingYoung Adult

Identifiers

PMID30730998
PMCPMC6366773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.